Karasawa Kazunori, Asano Kenichi, Moriyama Shigetaka, Ushiki Mikiko, Monya Misa, Iida Mayumi, Kuboki Erika, Yagita Hideo, Uchida Keiko, Nitta Kosaku, Tanaka Masato
Laboratory of Immune Regulation, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan; Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan;
Laboratory of Immune Regulation, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan; Japan Science and Technology Agency, PRESTO, Saitama, Japan; and.
J Am Soc Nephrol. 2015 Apr;26(4):896-906. doi: 10.1681/ASN.2014020195. Epub 2014 Sep 29.
Monocytes and kidney-resident macrophages are considered to be involved in the pathogenesis of renal ischemia-reperfusion injury (IRI). Several subsets of monocytes and macrophages are localized in the injured tissue, but the pathologic roles of these cells are not fully understood. Here, we show that CD169(+) monocytes and macrophages have a critical role in preventing excessive inflammation in IRI by downregulating intercellular adhesion molecule-1 (ICAM-1) expression on vascular endothelial cells. Mice depleted of CD169(+) cells showed enhanced endothelial ICAM-1 expression and developed irreversible renal damage associated with infiltration of a large number of neutrophils. The perivascular localization of CD169(+) monocytes and macrophages indicated direct interaction with blood vessels, and coculture experiments showed that the direct interaction of CD169(+) cell-depleted peripheral blood leukocytes augments the expression levels of ICAM-1 on endothelial cells. Notably, the transfer of Ly6C(lo) monocytes into CD169(+) cell-depleted mice rescued the mice from lethal renal injury and normalized renal ICAM-1 expression levels, indicating that the Ly6C(lo) subset of CD169(+) monocytes has a major role in the regulation of inflammation. Our findings highlight the previously unknown role of CD169(+) monocytes and macrophages in the maintenance of vascular homeostasis and provide new approaches to the treatment of renal IRI.
单核细胞和肾脏驻留巨噬细胞被认为参与了肾缺血再灌注损伤(IRI)的发病机制。单核细胞和巨噬细胞的几个亚群定位于受损组织,但这些细胞的病理作用尚未完全了解。在这里,我们表明,CD169(+)单核细胞和巨噬细胞通过下调血管内皮细胞上细胞间粘附分子-1(ICAM-1)的表达,在预防IRI中的过度炎症方面发挥关键作用。缺乏CD169(+)细胞的小鼠表现出内皮ICAM-1表达增强,并出现与大量中性粒细胞浸润相关的不可逆肾损伤。CD169(+)单核细胞和巨噬细胞的血管周围定位表明它们与血管直接相互作用,共培养实验表明,缺乏CD169(+)细胞的外周血白细胞的直接相互作用会增加内皮细胞上ICAM-1的表达水平。值得注意的是,将Ly6C(lo)单核细胞转移到缺乏CD169(+)细胞的小鼠中可使其免于致命的肾损伤,并使肾脏ICAM-1表达水平恢复正常,这表明CD169(+)单核细胞的Ly6C(lo)亚群在炎症调节中起主要作用。我们的研究结果突出了CD169(+)单核细胞和巨噬细胞在维持血管稳态方面以前未知的作用,并为肾IRI的治疗提供了新方法。